Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bridge expands China operations with new lab

This article was originally published in Scrip

Executive Summary

Bridge Laboratories is to start constructing a second Chinese research facility in Beijing in the fourth quarter of this year. The 150,000 sq ft building in the city's Zhongguancun Life Science Park is due for completion, in compliance withUS and international regulatory standards, in the fourth quarter of next year . It will provide a range of preclinical contract services, in areas including toxicology, immunology, vaccines and bioanalyis.. The facility will quadruple the US contract research firm's laboratory space in China, it says.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC003159

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel